BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Empagliflozin
1
Effect of empagliflozin on fractional excretion of sodium in patients with cirrhosis and refractory ascites
10/27/2025 10:57:52 AM | Browse: 200 | Download: 399
2
Metabolic and hepatic effects of semaglutide and empagliflozin on metabolic dysfunction-associated steatotic liver disease mice
10/27/2025 10:57:49 AM | Browse: 159 | Download: 375
3
Characteristic dysbiosis in patients with type 2 diabetes and hyperuricemia, and the effect of empagliflozin on gut microbiota
2/28/2025 10:47:09 AM | Browse: 163 | Download: 710
4
Comparative efficacy of sodium glucose cotransporter-2 inhibitors in the management of type 2 diabetes mellitus: A real-world experience
3/15/2024 9:49:53 AM | Browse: 221 | Download: 913
5
Elucidating the cardioprotective mechanisms of sodium-glucose cotransporter-2 inhibitors beyond glycemic control
2/4/2024 10:57:41 AM | Browse: 522 | Download: 1408
6
Empagliflozin ameliorates diabetic cardiomyopathy probably via activating AMPK/PGC-1a and inhibiting the RhoA/ROCK pathway
12/14/2023 9:36:12 AM | Browse: 290 | Download: 1452
7
Sodium-glucose Cotransporter-2 Inhibitors induced euglycemic diabetic ketoacidosis: A meta summary of case reports
8/11/2023 11:04:23 AM | Browse: 336 | Download: 1437
8
Potential for sodium-glucose cotransporter-2 inhibitors in the management of metabolic syndrome: A systematic review and meta-analysis
11/24/2022 8:01:57 AM | Browse: 611 | Download: 1499
9
Sodium-glucose co-transporter 2 inhibitors induced euglycemic diabetic ketoacidosis within four days of initiation
3/15/2022 2:23:07 PM | Browse: 554 | Download: 1111
10
Cardiovascular benefits from SGLT2 inhibition in type 2 diabetes mellitus patients is not impaired with phosphate flux related to pharmacotherapy
12/23/2021 6:10:00 AM | Browse: 612 | Download: 1096
11
Empagliflozin alleviates podocytopathy and enhances glomerular nephrin expression in db/db diabetic mice
12/13/2020 5:45:32 AM | Browse: 881 | Download: 2610
12
Role of sodium-glucose co-transporter-2 inhibitors in the management of heart failure in patients with diabetes mellitus
5/11/2020 9:58:04 AM | Browse: 1002 | Download: 1958
13
Bilateral gangrene of fingers in a patient on empagliflozin: First case report
2/18/2019 3:14:49 AM | Browse: 1076 | Download: 1689
14
Effects of glycaemic management on diabetic kidney disease
5/15/2017 10:13:33 AM | Browse: 1672 | Download: 2072
Write to the Help Desk
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345